Sculptor Capital LP Lannett CO Inc Transaction History

Sculptor Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	BUY	$4.75 - $14.5 $335,825 - $1.03 Million	70,700 Added 851.81%	79,000 $375,000
Q4 2017 Feb 13, 2018	SELL	$19.9 - $29.25 $730,330 - $1.07 Million	-36,700 Reduced 81.56%	8,300 $193,000
Q3 2017 Nov 13, 2017	BUY	$15.1 - $19.25 $679,500 - $866,250	45,000	45,000 $0

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Sculptor Capital LP, based on Form 13F filings with the SEC.

Stay updated on Sculptor Capital LP with notifications on news.